Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021

Cyclosporins

  • You have access
    Pharmacotherapy of multiple sclerosis: current status
    Richard A. Rudick, MD, Donald E. Goodkin, MD and Richard M. Ransohoff, MD
    Cleveland Clinic Journal of Medicine May 1992, 59 (3) 267-277;

    With careful drug selection and close monitoring, many symptoms associated with MS are effectively controlled.

  • You have access
    Experimental therapies for multiple sclerosis: current status
    Donald E. Goodkin, MD, Richard M. Ransohoff, MD and Richard A. Rudick, MD
    Cleveland Clinic Journal of Medicine January 1992, 59 (1) 63-74;

    A critical analysis of current experimental agents and obstacles to the development of effective drug therapy.

  • You have access
    Decreased infections in cardiac transplant recipients on cyclosporine with reduced corticosteroid use
    Margaret J. Gorensek, MD, Robert W. Stewart, MD, Thomas F. Keys, MD, Martin C. McHenry, MD, David L. Longworth, MD, Susan J. Rehm, MD and Theresa Babiak, BS
    Cleveland Clinic Journal of Medicine October 1989, 56 (7) 690-695;
  • You have access
    Cyclosporine nephrotoxicity
    Donald R. Steinmuller, MD
    Cleveland Clinic Journal of Medicine January 1989, 56 (1) 89-95;
  • You have access
    Cyclosporine and organ transplantation
    Donald R. Steinmuller, M.D.
    Cleveland Clinic Journal of Medicine June 1985, 52 (2) 263-270;

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire